Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany

• Những tác giả chính: Desmond Curran (Tác giả), Desirée Van Oorschot (Tác giả), Sean Matthews (Tác giả), Johannes Hain (Tác giả), Ahmed Ehab Salem (Tác giả), Magdalena Schwarz (Tác giả)
• Định dạng: Sách
• Được phát hành: Taylor & Francis Group, 2021-12-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

The aim of the study was to update previously published public health impact and cost-effectiveness analyses of the recombinant zoster vaccine (RZV), in the German population aged ≥50 years of age (YOA), with the latest vaccine efficacy (VE) estimates against herpes zoster (HZ). The updated estimate...